Geftiget 250mg Tablet

Geftiget 250mg Tablet is prescribed for cancer treatment It targets the epidermal growth factor receptor EGFR in both normal and cancer cells disrupting signals necessary for cancer cell growth Gefitinib is a cancer medication used to treat specific types of cancers by inhibiting cancer cell growth It targets the epidermal growth factor receptor EGFR present in healthy and cancerous cells By blocking specific proteins associated with this receptor Gefitinib disrupts the communication pathways crucial for cancer cell growth and survival effectively stopping uncontrolled cancer cell growth Follow the prescribed dose and duration as directed by your doctor Common side effects may include diarrhea dry skin loss of appetite nausea rash stomatitis vomiting weakness and weight loss It may also be associated with an increased risk of interstitial lung disease Patients should be monitored for symptoms such as cough difficulty breathing and fever Prompt medical attention is necessary if these symptoms occur If a dose is missed take it when remembered However if the next dose is close skip the missed one and continue with the regular dosing schedule Avoid doubling doses Consult your doctor for guidance on managing missed doses effectively